Ben Pouladian, CEO of BEP Holdings, to Join ISPE Los Angeles Biomanufacturing Panel
The Californer/10319440

LOS ANGELES - Californer -- LOS ANGELES, CA –– BEP Holdings announced today that its CEO, Ben Pouladian (LinkedIn (https://www.linkedin.com/in/benpouladian), X (https://x.com/benitoz)), will be a featured panelist at the ISPE Greater Los Angeles Area Chapter's upcoming "Resilient Life Sciences Ecosystem & Continuous Drug Discovery" program on July 9, 2025 (see LinkedIn panel announcement (https://www.linkedin.com/)). The International Society for Pharmaceutical Engineering (ISPE) Greater LA Chapter event, hosted at JLL's downtown Los Angeles office, will convene industry leaders to discuss strengthening biomanufacturing and life sciences innovation in the region.

Pouladian is an engineer-turned-entrepreneur and investor who leads BEP Holdings, a firm focused on life science ventures and infrastructure. Under his leadership, BEP Holdings has helped create much-needed lab space for technological research and development in the local biotech community , bridging critical infrastructure gaps in Los Angeles's life science sector. Pouladian also serves on the Leadership Board of the Terasaki Institute for Biomedical Innovation , a nonprofit research organization, reflecting his commitment to advancing medical research and innovation.

More on The Californer

• Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
• Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
• Ship Overseas Inc. Expands Specialized Shipping Services
• Governor Newsom announces additional deployment of California resources to support New Mexico following Texas and Oregon disaster response efforts
• Wise Business Plans® Earns Top Ratings as Leading Authority in Professional Business Plans

Pouladian's dedication to the life sciences is deeply personal. He lost his father to liver cancer and later his mother to non-small cell lung cancer —experiences that galvanized his mission to support life-saving innovations in healthcare. "After losing both my parents to cancer, I made it my mission to help advance better outcomes and therapies for others," said Pouladian. "By investing in innovative biotech companies and critical lab infrastructure, we can accelerate the development of new treatments so that families don't have to endure what mine did."

About BEP Holdings: BEP Holdings is a Los Angeles-based private investment firm dedicated to fostering innovation in life sciences and advanced technologies. The firm invests in early-stage biotech and pharmaceutical ventures and develops state-of-the-art laboratory facilities to support cutting-edge research. Under the leadership of CEO Ben Pouladian, BEP Holdings aims to accelerate the development of life-saving therapies by bridging gaps in resources and infrastructure within Southern California's life science ecosystem.